John D. Hancock

Partner, Co-Chair, Capital Markets Practice - Boston

Bio photo for John Hancock
Download Media Photo

Contact Information

John Hancock is a corporate partner with principal concentration on the securities matters involved in corporate financing transactions (both public offerings and private placements) and mergers and acquisitions. He represents clients in a variety of industries, but has a particular focus on high technology, software and medical device companies. John serves as Co-Chair of the firm's Capital Markets Practice.

More »

Education:

  • Harvard Law School, J.D., cum laude, 1992
  • University of Virginia, B.A. in Government and Foreign Affairs, with honors, Phi Beta Kappa, Omicron Delta Kappa, Pi Sigma Alpha, The Raven Society, 1989

Representative Experience

  • Has served as principal outside securities counsel to a variety of NYSE-listed and Nasdaq-listed companies in the medical device, biotechnology, software and technology industries
    • Regularly advise on corporate governance best practices, fiduciary obligations, breaking developments and SEC hot buttons
    • Advice has included challenging disclosure issues, including restatements, material weaknesses, internal investigations, executive terminations and securities litigation
  • Represented a specialty pharmaceutical company in its initial public offering
  • Represented a clinical-stage biotechnology company in its initial public offering
  • Represented a publicly traded medical device manufacturer in its sale to a private equity firm following a public auction process
  • Represented a publicly traded company in successfully defending a proxy contest by dissident shareholders
  • Represented a NYSE-listed diagnostics company in a variety of financing transactions, including:
    • Registered offering of $400 million of guaranteed senior subordinated notes
    • Registered offering of $150 million of guaranteed senior notes
    • Rule 144A/Regulation S “re-opening” offering of $100 million of guaranteed senior notes and related registered exchange offer
    • Rule 144A-for-life/Regulation S offering of $425 million of guaranteed senior subordinated notes
    • Rule 144A/Regulation S offering of $450 million of guaranteed senior notes and related registered exchange offer
    • Rule 144A/Regulation S offering of $425 million of guaranteed senior subordinated notes and related registered exchange offer
    • Rule 144A/Regulation S offering of $400 million of guaranteed senior subordinated notes and related registered exchange offer
    • Related tender offers and consent solicitations
  • Represented a publicly traded medical device company in its acquisition of numerous domestic and foreign publicly traded targets, including:
    • $350 million acquisition of a Nasdaq-listed issuer
    • $250 million acquisition of a Nasdaq-listed issuer
    • $200 million acquisition of an AIM-listed issuer
  • Represented numerous publicly traded companies in a variety of cash and stock acquisitions of private venture-backed targets
  • Represented a private medical device manufacturer in numerous reorganization, financing and refinancing transactions and foreign acquisitions
  • Represented a publicly traded company in a reverse merger transaction
  • Represented a publicly traded company in a PIPE financing and subsequent resale registration
  • Represented a Nasdaq-listed automation company in its acquisition of a publicly traded target listed on the Toronto Stock Exchange
  • Represented the dealer-manager of a reverse Dutch auction issuer tender offer
  • Represented a Nasdaq-listed medical device manufacturer in several confidentially marketed public offerings
  • Represented a Nasdaq-listed automation company in a merger-of-equals transaction
  • Represented an NYSE-listed medical device company in multiple acquisition, licensing and product manufacturing transactions
  • Represented a Nasdaq-listed technology company in a follow-on public offering
  • Represented a Nasdaq-listed professional services firm in its initial public offering and numerous follow-on public offerings
  • Represented a NYSE-listed information technology company in a follow-on public offering
  • Represented a NYSE-listed information technology company in a $300,000,000 Rule 144A offering of convertible senior notes
  • Represented the underwriters in the initial public offering of a Nasdaq-listed technology company
  • Represented the underwriters in the initial public offering and a follow-on offering of a Canadian Nasdaq-listed digital editing software company
  • Represented the underwriters in the initial public offering and a follow-on offering of a Nasdaq-listed supplier of modeling, simulation and optimization software
  • Represented a publicly traded department store company in a $195,000,000 Rule 144A offering of senior notes
  • Represented a Nasdaq-listed healthcare decision support software company in its initial public offering and subsequent acquisition by a strategic buyer
  • Represented a Nasdaq-listed developer of telecommunications hardware and software in its initial public offering
  • Represented the underwriters of a Nasdaq-listed healthcare information systems company in its initial public offering
  • Represented a Nasdaq-listed video conferencing company in its initial public offering and subsequent acquisition
  • Represented a private modeling software company in its $300 million acquisition by a publicly traded French company
  • Represented the underwriters of a Nasdaq-listed online retail company in its initial public offering
  • Represented the underwriters of a Nasdaq-listed online content company in a follow-on offering
  • Represented a Nasdaq-listed data analytics software company in its initial public offering and subsequent acquisition by a strategic buyer
  • Represented a Nasdaq-listed e-business software company in its sale to a strategic buyer
  • Represented numerous start-ups and other private companies in venture financings, angel investments and general corporate matters

Honors

  • Named a BTI Client Service All-Star, 2014
  • Harvard Environmental Law Review, Articles Editor, 1991-1992

Involvement

  • American Bar Association
    • Business Law Section, Member
    • Committee on Federal Securities Law, Member
  • Massachusetts Bar Association, Member
  • Boston Bar Association
    • Business Law Section, Member
    • Securities Law Committee, Member
    • Corporate Law Committee, Member
Add to Bio Folder

Download Bio

Bar Admissions

  • Massachusetts